Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1898 1
1901 5
1906 1
1908 2
1909 2
1911 1
1918 3
1922 1
1924 1
1937 1
1939 2
1946 3
1947 4
1948 4
1949 5
1950 9
1951 5
1952 6
1953 9
1954 8
1955 3
1956 9
1957 11
1958 4
1959 7
1960 10
1961 10
1962 5
1963 14
1964 9
1965 11
1966 7
1967 13
1968 10
1969 19
1970 34
1971 30
1972 15
1973 29
1974 28
1975 22
1976 33
1977 18
1978 37
1979 46
1980 41
1981 38
1982 59
1983 67
1984 97
1985 96
1986 97
1987 97
1988 105
1989 102
1990 114
1991 112
1992 113
1993 114
1994 137
1995 99
1996 98
1997 134
1998 112
1999 135
2000 134
2001 139
2002 170
2003 153
2004 188
2005 177
2006 209
2007 211
2008 208
2009 240
2010 237
2011 296
2012 305
2013 318
2014 326
2015 359
2016 382
2017 346
2018 405
2019 415
2020 468
2021 509
2022 465
2023 429
2024 76

Text availability

Article attribute

Article type

Publication date

Search Results

8,810 results

Results by year

Filters applied: . Clear all
Page 1
Developing dietary interventions as therapy for cancer.
Taylor SR, Falcone JN, Cantley LC, Goncalves MD. Taylor SR, et al. Nat Rev Cancer. 2022 Aug;22(8):452-466. doi: 10.1038/s41568-022-00485-y. Epub 2022 May 25. Nat Rev Cancer. 2022. PMID: 35614234 Review.
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Llibre JM, Brites C, Cheng CY, Osiyemi O, Galera C, Hocqueloux L, Maggiolo F, Degen O, Taylor S, Blair E, Man C, Wynne B, Oyee J, Underwood M, Curtis L, Bontempo G, van Wyk J. Llibre JM, et al. Among authors: taylor s. Clin Infect Dis. 2023 Feb 18;76(4):720-729. doi: 10.1093/cid/ciac130. Clin Infect Dis. 2023. PMID: 35235656 Free PMC article. Clinical Trial.
Unmet needs for patients with seborrheic dermatitis.
Jackson JM, Alexis A, Zirwas M, Taylor S. Jackson JM, et al. Among authors: taylor s. J Am Acad Dermatol. 2024 Mar;90(3):597-604. doi: 10.1016/j.jaad.2022.12.017. Epub 2022 Dec 17. J Am Acad Dermatol. 2024. PMID: 36538948 Free article. Review.
Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L, Moonen JR, Cao A, Isobe S, Li CG, Tojais NF, Taylor S, Marciano DP, Chen PI, Gu M, Li D, Harper RL, El-Bizri N, Kim YM, Stankunas K, Rabinovitch M. Wang L, et al. Among authors: taylor s. Circ Res. 2023 Mar 3;132(5):545-564. doi: 10.1161/CIRCRESAHA.121.320541. Epub 2023 Feb 6. Circ Res. 2023. PMID: 36744494 Free article.
A systematic review of multimodal prehabilitation in breast cancer.
Toohey K, Hunter M, McKinnon K, Casey T, Turner M, Taylor S, Paterson C. Toohey K, et al. Among authors: taylor s. Breast Cancer Res Treat. 2023 Jan;197(1):1-37. doi: 10.1007/s10549-022-06759-1. Epub 2022 Oct 21. Breast Cancer Res Treat. 2023. PMID: 36269525 Free PMC article. Review.
Author response.
Delaney BC, Rayner C, Freyer A, Taylor S, Järte L, MacDermott N, Nurek M. Delaney BC, et al. Among authors: taylor s. Br J Gen Pract. 2022 May 26;72(719):259-260. doi: 10.3399/bjgp22X719549. Print 2022 Jun. Br J Gen Pract. 2022. PMID: 35618450 Free PMC article. No abstract available.
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
Reynolds CJ, Pade C, Gibbons JM, Otter AD, Lin KM, Muñoz Sandoval D, Pieper FP, Butler DK, Liu S, Joy G, Forooghi N, Treibel TA, Manisty C, Moon JC; COVIDsortium Investigators§; COVIDsortium Immune Correlates Network§; Semper A, Brooks T, McKnight Á, Altmann DM, Boyton RJ, Abbass H, Abiodun A, Alfarih M, Alldis Z, Altmann DM, Amin OE, Andiapen M, Artico J, Augusto JB, Baca GL, Bailey SNL, Bhuva AN, Boulter A, Bowles R, Boyton RJ, Bracken OV, O'Brien B, Brooks T, Bullock N, Butler DK, Captur G, Carr O, Champion N, Chan C, Chandran A, Coleman T, Couto de Sousa J, Couto-Parada X, Cross E, Cutino-Moguel T, D'Arcangelo S, Davies RH, Douglas B, Di Genova C, Dieobi-Anene K, Diniz MO, Ellis A, Feehan K, Finlay M, Fontana M, Forooghi N, Francis S, Gibbons JM, Gillespie D, Gilroy D, Hamblin M, Harker G, Hemingway G, Hewson J, Heywood W, Hickling LM, Hicks B, Hingorani AD, Howes L, Itua I, Jardim V, Lee WJ, Jensen M, Jones J, Jones M, Joy G, Kapil V, Kelly C, Kurdi H, Lambourne J, Lin KM, Liu S, Lloyd A, Louth S, Maini MK, Mandadapu V, Manisty C, McKnight Á, Menacho K, Mfuko C, Mills K, Millward S, Mitchelmore O, Moon C, Moon J, Muñoz Sandoval D, Murray SM, Noursadeghi M, Otter A, Pade C, Pa… See abstract for full author list ➔ Reynolds CJ, et al. Among authors: taylor s. Science. 2022 Jul 15;377(6603):eabq1841. doi: 10.1126/science.abq1841. Epub 2022 Jul 15. Science. 2022. PMID: 35699621 Free PMC article.
8,810 results